ArticleBMC gastroenterology2025
Global, regional, and national burden of early-onset and late-onset colorectal cancer attributable to high body-mass index from 1990 to 2021: a trend analysis and forecasts up to 2040 based on the global burden of disease study 2021.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe global burden of colorectal cancer (CRC) has been steadily rising. However, a key knowledge gap persists regarding the HBMI-attributable burden in early-onset (EOCRC) versus late-onset (LOCRC) cases. The temporal patterns, geographic heterogeneity, and comparative trends remain poorly characterized, as prior studies often lack stratification by age of onset and detailed analysis across socio-demographic strata.
objectiveThis investigation seeks to systematically quantify the burden of EOCRC and LOCRC attributable to HBMI at global, regional, and national levels from 1990 to 2021 and provides projections of the burden through 2040.
methodsEpidemiological data, including number and rate for EOCRC and LOCRC were obtained from the Global Burden of Disease Study (GBD) 2021. Direct standardization method was employed to standardize rates across age-specific groups. The estimated annual percentage change (EAPC) model was utilized to analyze temporal trends from 1990 to 2021 across various countries, genders, SDI and GBD regions. Additionally, Nordpred and Bayesian age-period-cohort (BAPC) models were employed to forecast the burden of EOCRC and LOCRC owing to HBMI through 2040, both in terms of numbers and age-standardized rate (ASR).
resultsIn 2021, HBMI was responsible for 359,538 disability-adjusted life years (DALYs) and 7,255 deaths in EOCRC, as well as 2,005,125 DALYs and 92,013 deaths in LOCRC. From 1990 to 2021, there was an increase of 130.97% in DALYs and 130.24% in deaths associated with EOCRC, while LOCRC saw rises of 133.32% and 139.71%, respectively. The global age-standardized DALYs rate (ASDR) and age-standardized mortality rate (ASMR) both exhibited an upward trend in EOCRC, regardless of gender. Conversely, in LOCRC, the global ASDR remained stable, while the ASMR exhibited a slight decline, a trend that was more evident in females. A declining trend was noted specifically among females in high-middle socio-demographic index (SDI) regions for EOCRC, and across both genders in high SDI regions combine females in high-middle SDI regions for LOCRC, the remaining SDI regions demonstrated varying degrees of upward trends in both ASDR and ASMR. Among GBD regions, High-income North America had the highest ASDR and ASMR for EOCRC, while Central Europe recorded the highest ASDR and ASMR for LOCRC. In contrast, East Asia reported the highest number of DALYs and deaths for both EOCRC and LOCRC. Furthermore, a nonlinear relationship was observed between the ASR and SDI in GBD regions for both EOCRC and LOCRC attributable to HBMI. Projections based on Nordpred and BAPC models revealed a consistent global increase in DALYs, deaths, ASDR, and ASMR for both EOCRC and LOCRC.
conclusionFrom 1990 to 2021, the global burden of LOCRC attributable to HBMI remains significantly high and consistently exceeds that of EOCRC, but the rapid growth of EOCRC should be emphasized. The burden of CRC is closely associated with the SDI. While LOCRC has begun to decline in high-SDI regions, EOCRC continues to increase across all SDI regions. Over the next 20 years, the burden caused by EOCRC and LOCRC is expected to continue increasing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.